Grx2 exists in two isoforms in yeast: a long form and a short form. These isoforms are produced through differential translation initiation from two in-frame start codons within the GRX2 gene. The long form is targeted to the mitochondria, while the short form is found in the cytosol . The long form predominates during the exponential phase of yeast growth in standard yeast extract/peptone/dextrose (YPD) medium .
Grx2 functions as a classical glutaredoxin, efficiently catalyzing the reduction of hydroxyethyl disulfide by glutathione (GSH). It also catalyzes the reduction of glutathione disulfide (GSSG) by dihydrolipoamide with even higher efficiency . These activities are essential for maintaining the redox balance within the cell and protecting against oxidative damage.
Recombinant yeast Grx2p is typically expressed in Escherichia coli for research purposes. This allows for the production of large quantities of the protein, which can then be purified and studied in detail. The recombinant protein behaves similarly to the native protein, making it a valuable tool for biochemical and structural studies .
The study of Grx2 has provided significant insights into the mechanisms of oxidative stress defense in yeast. Understanding how Grx2 and other glutaredoxins function can help in developing strategies to enhance stress resistance in industrial yeast strains, which is important for various biotechnological applications.
In summary, Glutaredoxin 2 from yeast is a vital protein involved in oxidative stress defense, with distinct isoforms that localize to different cellular compartments. Its recombinant expression in E. coli has facilitated detailed studies, contributing to our understanding of cellular redox regulation.